Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2021

Mar 19, 2021

33728_dirs_2021-03-18_34b29156-18cd-4de1-b4d8-d865125a8d28.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-18

Reporting Person: Binder Gwendolyn (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $0.35 2029-09-05 Common Stock (12000) Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vested on June 24, 2019, and the remaining shares subject to the option vested or shall vest
in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.